About Pivot Bio
Pivot Bio is a Healthcare company based in Berkeley (United States) founded in 2010 by Alvin Tamsir and Karsten Temme. Nitrogen-fixing microbes for corn crop nutrition are developed and applied. It operates in the Healthcare, Agriculture, and Chemicals & Materials sectors. Pivot Bio has raised $618.08 million across 7 funding rounds from investors including Gates, Monsanto and Bunge. The company has 307 employees. Pivot Bio was last valued at $1.7 billion in June 2025. Its chief executive, as recorded, is Chris Abbott. Its website pivotbio.com draws about 15 thousand monthly visits. Pivot Bio offers products and services including PROVEN® 40, RETURN®, and N-OVATOR Program. Its focus areas include Life Sciences, Genomics, Applied Genomics and Synthetic Biology. Its competitors include Amyris, Ginkgo Bioworks and Asimov; 3 of its 3 listed competitors have raised funding.
Company details
Pivot Bio was founded in 2010 and is headquartered in Berkeley, United States. Microbe-based products for crop nutrition are developed within the agricultural biotechnology sector. Nitrogen-fixing microorganisms are engineered to establish symbiotic relationships with corn plants, converting atmospheric nitrogen into usable forms directly at the roots through biological processes. Application occurs via an in-furrow method, with consistent performance across varying topography, weather conditions, and soil types.
- Total Equity Funding$618.08M (USD)
in 7 rounds
- Latest Funding Round$430M (USD), Series D
Jul 2021
- InvestorsGates
& 25 more
- Employee Count307
Products & Services of Pivot Bio
Pivot Bio offers a comprehensive portfolio of products and services, including PROVEN® 40, RETURN®, and N-OVATOR Program.
Delivers steady nutrition for corn crops to enhance yield.
Boosts nutrition for wheat and small grains productivity.
Rewards farmers for using microbial nitrogen to cut emissions.
Apps and channels of Pivot Bio
its YouTube channel Pivot Bio has 2.18K subscribers and 30 videos.
Videos from Pivot Bio
The most watched videos on Pivot Bio's YouTube channel, Pivot Bio (2.18K subscribers). Click a video to play it here.
More on Pivot Bio.
Funding Insights of Pivot Bio
Pivot Bio has successfully raised a total of $618.08M across 7 strategic funding rounds. The most recent funding activity was a Series D round of $430 million completed in July 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $618.08M
- Total Rounds 7
- Last Round Series D — $430M
- First Round $749,998
(Oct 2014)
- Investors Count 26
All 7 funding rounds of Pivot Bio with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul 2021 | $430M | Series D | $2B | DCVC, Temasek | |
| May 2020 | $100M | Series C | – | Temasek, Breakthrough Energy | |
| Oct 2018 | $71.33M | Series B | – | Breakthrough Energy | |
| Jun 2017 | Series A | – | bayers.com | – | |
| Jan 2016 | $16M | Series A | – | DCVC, Monsanto | |
| Jul 2015 | $150,000 | Grant | – | – | |
| Oct 2014 | $749,998 | Seed | – | DCVC, Monsanto | – |
| Date | Valuation | Stage |
|---|---|---|
| Jul 2021 | $2B | •••••••• |
Last known valuation $1.7B (Jun 2025). 26 investors in total: 24 institutional and 2 angel.
Investors in Pivot Bio
Pivot Bio has secured backing from 26 investors, including venture fund, institutional, and angel investors. Prominent investors backing the company include Gates, Monsanto and Bunge.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Venture capital firm focused on multiple sectors | dcvc.com | Palo Alto, United States | ||
An investment platform is provided for diverse sectors and geographies. | 1974 | temasek.com.sg | Singapore, Singapore | |
Private equity firm focused on sustainable investments | generationim.com | London, United Kingdom | ||
Venture capital fund investing in tech companies | g2vp.com | Portola Valley, United States | ||
Climate companies are invested in by this venture capital firm. | preludeventures.com | San Francisco, United States | ||
Investments are directed to food, agribusiness, and commodities sectors. | continentalgrain.com | New York, United States | ||
| codoncapital.com | ||||
Venture capital firm backed by Tekfen Holding | tekfenventures.com | New York, United States | ||
Growth-stage companies are invested in by this venture capital fund. | pavilioncapital.com | New York, United States | ||
Climate solutions are advanced via venture capital and startup acceleration. | breakthroughenergy.org | Kirkland, United States |
Investor details for Pivot Bio
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Pivot Bio
117 people are tracked at Pivot Bio (38 in leadership, 16 in board & advisors, 63 in team); the tracked headcount is 307.
| Name | Role | Group |
|---|---|---|
Alvin Tamsir | Co-Founder & Chief Science Officer | Leadership |
Karsten Temme | Co-Founder & Chief Innovation Officer | Leadership |
Chris Abbott | CEO | Leadership |
Mahira Sheikh | Director Of Accounting | Leadership |
Richard Broglie | Chief Technology Officer | Leadership |
Erik Christian | Director, Product Development Agronomy | Leadership |
Christopher Abbott | CEO | Leadership |
Dan Poston | Vice President Field R & D | Leadership |
Tim Learmonth | Associate Director Of Data Science | Leadership |
Kim Craig - | Director, People Parterning | Leadership |
Wendy Watkins | Chief Communications Officer (cco) | Leadership |
Lori Reese | Senior Director, Commercial Sustainability | Leadership |
Bob Houghton | Chief Financial Officer | Leadership |
Ricardo Reis | Head Of Commercial Strategy & Marketing | Leadership |
Megan Atiyeh | Director Employee Communications | Leadership |
Debra Frimerman | Chief Legal Officer | Leadership |
Jonathan Fu | Head Of Fp&a | Leadership |
Ritesh Agrawal | Director Of Intellectual Property | Leadership |
Jodi Bos | Director, Incentives And Special Events | Leadership |
Amanda Barry | Associate General Counsel- Head Of IP | Leadership |
97 more people are available in the full profile.
Complete people profiles for Pivot Bio
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Pivot Bio
4 dated milestones of Pivot Bio across 11 years, from founding to its latest funding, stage changes and deals.
- Founded Pivot Bio is founded.
- Funding First funding round of $750K.
- Funding Latest funding round, Series D, of $430.0M.
- Milestone Reaches Unicorn status.
Competitors of Pivot Bio
Pivot Bio has 3 listed competitors in our database, 3 of them funded. They include Amyris, Ginkgo Bioworks and Asimov.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| amyris.com | 2003 | Emeryville, United States | $487.2M | 747 | Developer of renewable products for industrial solutions | |
| ginkgobioworks.com | 2008 | Boston, United States | $795.75M | 1,218 | Gene editing-based cultured ingredients are provided for agriculture. | |
| asimov.com | 2017 | Boston, United States | $209.4M | 87 | Provider of integrated suite for advanced genetic design and manufacturing |
Detailed competitors of Pivot Bio
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Pivot Bio
The website of Pivot Bio (pivotbio.com) receives about 14.8K visits a month.
- Monthly visits14.8K
▲ 67% vs previous month
Websites whose visitors overlap most with Pivot Bio. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| synbiobeta.com | 100% | #979,192 | View details |
Top companies in Genomics & Gene Therapy Platforms
3 companies that operate in the same segment as Pivot Bio (Genomics & Gene Therapy Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Pivot Bio
Complete news archive for Pivot Bio
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Pivot Bio
Pivot Bio was founded in 2010 and raised its 1st funding round 4 years after it was founded.
Pivot Bio is headquartered in Berkeley, United States. It is registered at Berkeley, California, United States.
Chris Abbott is the CEO of Pivot Bio, as recorded in our data.
Pivot Bio is a funded company, having raised a total of $618.08M across 7 funding rounds to date. The company's 1st funding round was a Seed of $750K, raised on Oct 2014.
Pivot Bio has 307 employees.
Pivot Bio was founded in 2010 and is headquartered in Berkeley, United States. Microbe-based products for crop nutrition are developed within the agricultural biotechnology sector. Nitrogen-fixing microorganisms are engineered to establish symbiotic relationships with corn plants, converting atmospheric nitrogen into usable forms directly at the roots through biological processes. Application occurs via an in-furrow method, with consistent performance across varying topography, weather conditions, and soil types.
Pivot Bio's top competitors include Amyris, Asimov and Ginkgo Bioworks.
Pivot Bio offers PROVEN® 40, RETURN®, and N-OVATOR Program.
Pivot Bio has 26 investors. Key investors include Gates, Monsanto, Bunge, Rockefeller Capital Management, and Temasek.
The valuation of Pivot Bio is $1.7B as of Jun 2025.